중증 신종인플루엔자의 치료

참고문헌 (37)

1. Dwyer D, "Mini-lecture In Slide session on Novel H1N1 influenza: late-breakers in Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy", American Society for Microbiology
3. Zilberberg MD, "Swine origin influenza A (H1N1) virus and ICU capacity in the US: Are we prepated?", PLoS Currents Influenza, 22, pp.RRN1009~ (2009)
4. Sweet M, "Pandemic lessons from Australia", Brit Med J, 339, pp.b3317~ (2009)
5. Flahault A, "First estimation of direct H1N1pdm virulence: From reported non consolidated data from Mauritius and New Caledonia", PLoS Currents Influenza, pp.RRN1010~ (2009)
6. Rello J, "the H1N1 SEMICYUC working group", Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care, 13, pp.R148~ (2009)
7. Vaillant L, "Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009", Euro Surveill, 14, pp.19309~ (2009)
8. Wilson N, "The emerging influenza pandemic: estimating the case fatality ratio", Euro Surveill, 14, pp.19255~ (2009)
9. Miller MA, "The signature features of influenza pandemics-implications for policy", N Engl J Med, 360, pp.2595~2598 (2009)
10. Nishiura H, "Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic", PLoS One, 4, pp.e6852~ (2009)
11. Ruiz-Palacios GM, "Ground zero: the emgergence of a pandemic? In Symphosium on Influenza: experiencing the unexpected in Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy" (2009), American Society for Microbiology
12. Hancock K, "Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus", N Engl J Med 2009
13. Itoh Y, "In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses", Nature, 460, pp.1021~1025 (2009)
14. Neumann G, "Emergence and pandemic potential of swine-origin H1N1 influenza virus", Nature, 459, pp.931~939 (2009)
15. Tumpey TM, "Characterization of the reconstructed 1918 Spanish influenza pandemic virus", Science, 310, pp.77~80 (2005)
16. Mcculiers JA, "Influenza and bacteria: a lethal syngergism? In Symphosium on Influenza: experiencing the unexpected in Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy" (2009), American Society for Microbiology
17. Morens DM, "Understanding influenza backward", JAMA, 302, pp.679~680 (2009)
18. Maines TR, "Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice", Science, 325, pp.484~487 (2009)
19. Munster VJ, "Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets", Science, 325, pp.481~483 (2009)
20. Perez-Padilla R, "INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico", N Engl J Med, 361, pp.680~689 (2009)
21. 09. Late-breaker poster session (V-1074i) in Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, "Evidence of viremia in two cases of severe pandemic influenza A H1N1", pp.2009, Oughton MT
22. 09 influenza complicated by community-acquired methicillin- resistant Staphylococcus aureus in Program and abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, "Two fatal pediatric cases of pandemic H1N1", pp.2009, Johnson KK
23. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, "Update on avian influenza A (H5N1) virus infection in humans", N Engl J Med, 358, pp.261~273 (2008)
24. Centers for Disease Control and Prevention (CDC), "Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009", MMWR Morb Mortal Wkly Rep, 58, pp.749~752 (2009)
25. Lee N, "Viral loads and duration of viral shedding in adult patients hospitalized with influenza", J Infect Dis, 200, pp.492~500 (2009)
26. Smee DF, "Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice", Antimicrob Agents Chemother, 53, pp.2120~2128 (2009)
27. Nguyen JT, "Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro", Antimicrob Agents Chemother, 53, pp.4115~4126 (2009)
28. H1N1 virus in Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, "In vitro synergy of antiviral combinations against novel influenza A", pp.2009, Nguyen JT
29. Kuiken T, "Pathology of human influenza revisited", Vaccine, 26(4), pp.D59~D66 (2008)
30. Centers for Disease Control and Prevention(CDC), "Surveillance for pediatric deaths associated with 2009 pandemic influenza A(H1N1)virus infection-Unites States,April-August 2009", April-August 2009, 58, pp.941~945 (2009)
31. Barlow GD, "on behalf of the BSAC Council. Swine flu and antibiotics", J Antimicrob Chemother, 64, pp.889~894 (2009)
32. Liem NT, "Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006", Clin Infect Dis, 48, pp.1639~1646 (2009)
33. Luke TC, "Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?", Ann Intern Med, 145, pp.599~609 (2006)
34. Simmons CP, "Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza", PLoS Med, 4, pp.e178~ (2007)
35. Zhou B, "Treatment with convalescent plasma for influenza A (H5N1) infection", N Engl J Med, 357, pp.1450~1451 (2007)
37. "Community Strategy for Pandemic Influenza Mitigation"[URL]

관련 논문AI추천